For the year ending 2025-12-31, QTRX had -$27,713K decrease in cash & cash equivalents over the period. -$79,848K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -107,150 |
| Depreciation and amortization expense | 15,844 |
| Credit losses on accounts receivable | 628 |
| Accretion of marketable securities | 2,078 |
| Operating lease right-of-use asset amortization | 3,081 |
| Stock-based compensation expense | 20,718 |
| Impairment | 7,752 |
| Change in fair value of contingent liabilities | -4,547 |
| Recognition of off-market liability | -2,726 |
| Deferred taxes | -5,867 |
| Other operating activity | 540 |
| Accounts receivable | -10,609 |
| Inventory | -4,033 |
| Prepaid expenses and other current assets | -3,521 |
| Other non-current assets | -252 |
| Accounts payable | -528 |
| Accrued compensation and benefits, accrued expenses, and other current liabilities | -7,914 |
| Net change in other operating assets and liabilities | 12,324 |
| Net cash used in operating activities | -77,236 |
| Purchases of marketable debt securities | 69,757 |
| Proceeds from sales and maturities of marketable securities | 215,829 |
| Purchases of property and equipment | 2,612 |
| Acquisitions, net of cash acquired | 93,229 |
| Net cash provided by (used in) investing activities | 50,231 |
| Proceeds from common stock issued under stock plans | 738 |
| Payments for employee taxes withheld on stock-based compensation awards | 1,446 |
| Net cash provided by (used in) financing activities | -708 |
| Net decrease in cash, cash equivalents, and restricted cash | -27,713 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 1,574 |
| Cash, cash equivalents, and restricted cash at beginning of period | 59,319 |
| Cash, cash equivalents, and restricted cash at end of period | 33,180 |
Quanterix Corp (QTRX)
Quanterix Corp (QTRX)